Gilead HIV Drug Fight Begins Rare Summary Jury Trial

By Dorothy Atkins · May 15, 2023, 8:26 PM EDT

Gilead Sciences Inc.'s yearslong legal battle with consumers over consolidated claims that the pharmaceutical giant hid the side effects of its anti-HIV drug Truvada saw the start of the first of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Holley et al v. Gilead Sciences, Inc.

Case Number

Court

California Northern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

November 16, 2018

Recent Articles By Dorothy

July 18, 2024
Abbott Wins Trust Asset Freeze To Collect $33M In TM Fight
July 16, 2024
Masimo Accuses Politan Of Deceit In Hostile Takeover
July 12, 2024
Whistleblower's Attys Get $5.9M After Losing $11.5M Fee Ask
July 12, 2024
Military's IVF Policy Defense Fails Post-Chevron, Group Says
June 14, 2024
Janssen Hit With $150M Verdict In HIV Drug False Claims Suit
May 02, 2024
Calif. Justices To Review Gilead's HIV Drug Negligence Fight
May 01, 2024
J&J Unit Cuts Deal To End Cancer Drug Trade Secret Fight
February 28, 2024
AdaptHealth, Ex-CEO Cut $51M Deal To End Investor Fight
January 24, 2024
US News Sues SF City Atty Over 'Best Hospitals' Probe
January 12, 2024
Feds Seek Prison Time For Ex-NBA Player In Health Fraud Suit